Jessica Heejong Lee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jessica Heejong Lee has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- David J. Torpy
Endocrine and Metabolic Unit, Royal Adelaide Hospital, Adelaide, Australia
4 shared publications - Morten Thaysen-Andersen
School of Natural Sciences, Faculty of Science and Engineering, Macquarie University
3 shared publications Emily J Meyer
Department of Medicine, University of Adelaide , Adelaide, SA 5000
2 shared publications- Emily Jane Meyer
Metabolic and Bariatric Clinic, Central Adelaide Local Health Network (CALHN), Adelaide, SA, Australia; Endocrine and Metabolic Unit, Royal Adelaide Hospital, CALHN, Adelaide, SA, Australia; Endocrine and Diabetes Services, Queen Elizabeth Hospital, CALHN, Adelaide, SA, Australia; Discipline of Medicine, Adelaide Medical School, Adelaide University, Adelaide, SA, Australia; Upper Gastrointestinal Surgery, Royal Adelaide Hospital, CALHN, Adelaide, SA, Australia
2 shared publications Marni Nenke
Department of Medicine, University of Adelaide , Adelaide, SA 5000
2 shared publications- Zeynep Sumer-Bayraktar
School of Natural Sciences, Faculty of Science and Engineering, Macquarie University
2 shared publications
Latest Publications
- Open Access
- 13 March 2026
- Published by The Endocrine Society in Journal of the Endocrine Society
- Vol. 10 (5) , bvag058
TS3 Asn347 corticosteroid-binding globulin (CBG) glycoform deficiency is associated with mortality in human septic shock
Context: Corticosteroid-binding globulin (CBG) deficiency is an independent predictor of intensive care unit (ICU) mortality in septic shock. CBG glycosylation at the Asn347 site affects neutrophil elastase cleavage susceptibility, altering CBG:cortisol binding affinity, and may underlie this association. Objective: This work aimed to analyze CBG Asn347 glycoforms in patients with septic shock and determine their relationship to mortality and illness severity. Methods: CBG Asn347 site glycosylation profiling was performed by mass spectrometry in 128 septic shock patients from a tertiary hospital ICU at day 1 and last day of admission up to 7 days. ICU and 28-day mortality were analyzed by a Cox proportional hazards model, sequentially correcting for illness severity (APACHE score) and total CBG (all glycoforms). Results: Only triantennary trisialylated (TS3) Asn347 CBG glycoform concentrations were lower in ICU septic shock nonsurvivors than in survivors (29.74 vs 45.16 nmol/L; P = 0.007). On Cox multivariate analysis correcting for APACHE score, lowest tertile of TS3 Asn347 CBG glycoform concentration (<27.9 nmol/L) was associated with increased ICU mortality (adjusted hazard ratio [HR] 2.7; 95% CI, 1.2-6.2; P = .023) and was the only Asn347 glycoform demonstrating such an association. TS3 Asn347 CBG glycoform concentration less than 27.9 nmol/L was also associated with increased 28-day mortality (adjusted HR 2.2; 95% CI, 1.1-4.4; P = .023), which was not the case with lowest tertile of total CBG concentration (<200 nmol/L). Conclusion: Deficiency of the Asn347 TS3 CBG glycoform is associated with ICU and 28-day mortality in septic shock.
- 13 March 2026
- Published by The Endocrine Society in Journal of the Endocrine Society
- Vol. 10 (5) , bvag058
Open AccessTS3 Asn347 corticosteroid-binding globulin (CBG) glycoform deficiency is associated with mortality in human septic shock
Context: Corticosteroid-binding globulin (CBG) deficiency is an independent predictor of intensive care unit (ICU) mortality in septic shock. CBG glycosylation at the Asn347 site affects neutrophil elastase cleavage susceptibility, altering CBG:cortisol binding affinity, and may underlie this association. Objective: This work aimed to analyze CBG Asn347 glycoforms in patients with septic shock and determine their relationship to mortality and illness severity. Methods: CBG Asn347 site glycosylation profiling was performed by mass spectrometry in 128 septic shock patients from a tertiary hospital ICU at day 1 and last day of admission up to 7 days. ICU and 28-day mortality were analyzed by a Cox proportional hazards model, sequentially correcting for illness severity (APACHE score) and total CBG (all glycoforms). Results: Only triantennary trisialylated (TS3) Asn347 CBG glycoform concentrations were lower in ICU septic shock nonsurvivors than in survivors (29.74 vs 45.16 nmol/L; P = 0.007). On Cox multivariate analysis correcting for APACHE score, lowest tertile of TS3 Asn347 CBG glycoform concentration (<27.9 nmol/L) was associated with increased ICU mortality (adjusted hazard ratio [HR] 2.7; 95% CI, 1.2-6.2; P = .023) and was the only Asn347 glycoform demonstrating such an association. TS3 Asn347 CBG glycoform concentration less than 27.9 nmol/L was also associated with increased 28-day mortality (adjusted HR 2.2; 95% CI, 1.1-4.4; P = .023), which was not the case with lowest tertile of total CBG concentration (<200 nmol/L). Conclusion: Deficiency of the Asn347 TS3 CBG glycoform is associated with ICU and 28-day mortality in septic shock.
- Open Access
- 28 February 2025
- Published by Oxford University Press (OUP) in Glycobiology
- Vol. 35 (4)
RCL glycosylation of serum corticosteroid-binding globulin: implications in cortisol delivery and septic shock
Corticosteroid-binding globulin (CBG) is a serum glycoprotein that binds and delivers anti-inflammatory cortisol to inflammatory sites through neutrophil elastase-mediated proteolysis of an exposed reactive centre loop (RCL) on CBG. Timely and tissue-specific delivery of cortisol is critical to alleviate inflammation including in life-threatening septic shock conditions. Herein, we firstly summarise our recently published report of functional RCL O- and N-glycosylation events of serum CBG (Chernykh, J Biol Chem, 2023). A key finding of that published work was the LC–MS/MS-based discovery of RCL O-glycans at Thr342 and Thr345 of serum CBG and their inhibitory roles in neutrophil elastase-mediated RCL proteolysis. While these observations are of significance as they implicate RCL O-glycosylation as a potential regulator of cortisol delivery, the link to septic shock remains unexplored. To this end, we used a similar LC–MS/MS approach to profile the RCL O-glycosylation of CBG purified from serum of twelve septic shock patients. Serum CBG from all patients exhibited RCL O-glycosylation comprising (di)sialyl T (NeuAc1-2Gal1GalNAc1) core 1-type O-glycan structures decorating exclusively the Thr342 site. Importantly, relative to less severe cases, individuals presenting with the most severe illness displayed elevated RCL O-glycosylation upon ICU admission, suggesting a previously unknown link to septic shock severity. Overall, we have elucidated the coordinated RCL N- and O-glycosylation events of serum CBG, which improve our understanding of molecular mechanisms governing the timely and tissue-specific delivery of cortisol to inflammatory sites. This work provides clues to molecular aberrations and disease mechanisms underpinning septic shock.
- 28 February 2025
- Published by Oxford University Press (OUP) in Glycobiology
- Vol. 35 (4)
Open AccessRCL glycosylation of serum corticosteroid-binding globulin: implications in cortisol delivery and septic shock
Corticosteroid-binding globulin (CBG) is a serum glycoprotein that binds and delivers anti-inflammatory cortisol to inflammatory sites through neutrophil elastase-mediated proteolysis of an exposed reactive centre loop (RCL) on CBG. Timely and tissue-specific delivery of cortisol is critical to alleviate inflammation including in life-threatening septic shock conditions. Herein, we firstly summarise our recently published report of functional RCL O- and N-glycosylation events of serum CBG (Chernykh, J Biol Chem, 2023). A key finding of that published work was the LC–MS/MS-based discovery of RCL O-glycans at Thr342 and Thr345 of serum CBG and their inhibitory roles in neutrophil elastase-mediated RCL proteolysis. While these observations are of significance as they implicate RCL O-glycosylation as a potential regulator of cortisol delivery, the link to septic shock remains unexplored. To this end, we used a similar LC–MS/MS approach to profile the RCL O-glycosylation of CBG purified from serum of twelve septic shock patients. Serum CBG from all patients exhibited RCL O-glycosylation comprising (di)sialyl T (NeuAc1-2Gal1GalNAc1) core 1-type O-glycan structures decorating exclusively the Thr342 site. Importantly, relative to less severe cases, individuals presenting with the most severe illness displayed elevated RCL O-glycosylation upon ICU admission, suggesting a previously unknown link to septic shock severity. Overall, we have elucidated the coordinated RCL N- and O-glycosylation events of serum CBG, which improve our understanding of molecular mechanisms governing the timely and tissue-specific delivery of cortisol to inflammatory sites. This work provides clues to molecular aberrations and disease mechanisms underpinning septic shock.
- Open Access
- 20 December 2024
- Published by Elsevier in Clinica Chimica Acta
- Vol. 567, 120108
Mass spectrometric detection of neutrophil elastase cleaved corticosteroid binding globulin and its association with Asn347 site glycosylation, in septic shock patients
- 20 December 2024
- Published by Elsevier in Clinica Chimica Acta
- Vol. 567, 120108
Open AccessMass spectrometric detection of neutrophil elastase cleaved corticosteroid binding globulin and its association with Asn347 site glycosylation, in septic shock patients
- Top Cited Papers
- 15 June 2024
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 109 (9) , 2161-2172
Cortisol, Stress, and Disease—Bidirectional Associations; Role for Corticosteroid-Binding Globulin?
Selye described stress as a unified neurohormonal mechanism maintaining homeostasis. Acute stress system activation is adaptive through neurocognitive, catecholaminergic, and immunomodulation mechanisms, followed by a reset via cortisol. Stress system components, the sympathoadrenomedullary system, hypothalamic-pituitary-adrenal axis, and limbic structures are implicated in many chronic diseases by establishing an altered homeostatic state, allostasis. Consequent “primary stress system disorders” were popularly accepted, with phenotypes based on conditions such as Cushing syndrome, pheochromocytoma, and adrenal insufficiency. Cardiometabolic and major depressive disorders are candidates for hypercortisolemic etiology, contrasting the “hypocortisolemic symptom triad” of stress sensitivity, chronic fatigue, and pain. However, acceptance of chronic stress etiology requires cause-and-effect associations, and practical utility such as therapeutics altering stress system function. Inherent predispositions to stress system perturbations may be relevant. Glucocorticoid receptor (GR) variants have been associated with metabolic/neuropsychological states. The SERPINA6 gene encoding corticosteroid-binding globulin (CBG), was the sole genetic factor in a single-nucleotide variation–genome-wide association study linkage study of morning plasma cortisol, a risk factor for cardiovascular disease, with alterations in tissue-specific GR-related gene expression. Studies showed genetically predicted high cortisol concentrations are associated with hypertension and anxiety, and low CBG concentrations/binding affinity, with the hypocortisolemic triad. Acquired CBG deficiency in septic shock results in 3-fold higher mortality when hydrocortisone administration produces equivocal results, consistent with CBG's role in spatiotemporal cortisol delivery. We propose some stress system disorders result from constitutional stress system variants rather than stressors themselves. Altered CBG:cortisol buffering may influence interstitial cortisol ultradian surges leading to pathological tissue effects, an example of stress system variants contributing to stress-related disorders.
- 15 June 2024
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 109 (9) , 2161-2172
Top Cited PapersCortisol, Stress, and Disease—Bidirectional Associations; Role for Corticosteroid-Binding Globulin?
Selye described stress as a unified neurohormonal mechanism maintaining homeostasis. Acute stress system activation is adaptive through neurocognitive, catecholaminergic, and immunomodulation mechanisms, followed by a reset via cortisol. Stress system components, the sympathoadrenomedullary system, hypothalamic-pituitary-adrenal axis, and limbic structures are implicated in many chronic diseases by establishing an altered homeostatic state, allostasis. Consequent “primary stress system disorders” were popularly accepted, with phenotypes based on conditions such as Cushing syndrome, pheochromocytoma, and adrenal insufficiency. Cardiometabolic and major depressive disorders are candidates for hypercortisolemic etiology, contrasting the “hypocortisolemic symptom triad” of stress sensitivity, chronic fatigue, and pain. However, acceptance of chronic stress etiology requires cause-and-effect associations, and practical utility such as therapeutics altering stress system function. Inherent predispositions to stress system perturbations may be relevant. Glucocorticoid receptor (GR) variants have been associated with metabolic/neuropsychological states. The SERPINA6 gene encoding corticosteroid-binding globulin (CBG), was the sole genetic factor in a single-nucleotide variation–genome-wide association study linkage study of morning plasma cortisol, a risk factor for cardiovascular disease, with alterations in tissue-specific GR-related gene expression. Studies showed genetically predicted high cortisol concentrations are associated with hypertension and anxiety, and low CBG concentrations/binding affinity, with the hypocortisolemic triad. Acquired CBG deficiency in septic shock results in 3-fold higher mortality when hydrocortisone administration produces equivocal results, consistent with CBG's role in spatiotemporal cortisol delivery. We propose some stress system disorders result from constitutional stress system variants rather than stressors themselves. Altered CBG:cortisol buffering may influence interstitial cortisol ultradian surges leading to pathological tissue effects, an example of stress system variants contributing to stress-related disorders.
- 31 January 2023
- Published by Wiley in Liver International
- Vol. 43 (3) , 740-741
Plasma corticosteroid‐binding globulin concentrations are preserved in mild cirrhosis
- 31 January 2023
- Published by Wiley in Liver International
- Vol. 43 (3) , 740-741
Plasma corticosteroid‐binding globulin concentrations are preserved in mild cirrhosis
- 11 July 2022
- Published by Springer Nature in Reviews in Endocrine and Metabolic Disorders
- Vol. 24 (1) , 57-69
Adrenal insufficiency in pregnancy: Physiology, diagnosis, management and areas for future research
Adrenal insufficiency requires prompt diagnosis in pregnancy, as untreated, it can lead to serious consequences such as adrenal crisis, intrauterine growth restriction and even foetal demise. Similarities between symptoms of adrenal insufficiency and those of normal pregnancy can complicate diagnosis. Previously diagnosed adrenal insufficiency needs monitoring and, often, adjustment of adrenal hormone replacement. Many physiological changes occur to the hypothalamic–pituitary–adrenal (HPA) axis during pregnancy, often making diagnosis and management of adrenal insufficiency challenging. Pregnancy is a state of sustained physiologic hypercortisolaemia; there are multiple contributing factors including high plasma concentrations of placental derived corticotropin-releasing hormone (CRH), adrenocorticotropin (ACTH) and increased adrenal responsiveness to ACTH. Despite increased circulating concentrations of CRH-binding protein (CRH-BP) and the major cortisol binding protein, corticosteroid binding globulin (CBG), free concentrations of both hormones are increased progressively in pregnancy. In addition, pregnancy leads to activation of the renin–angiotensin–aldosterone system. Most adrenocortical hormone diagnostic thresholds are not applicable or validated in pregnancy. The management of adrenal insufficiency also needs to reflect the physiologic changes of pregnancy, often requiring increased doses of glucocorticoid and at times mineralocorticoid replacement, especially in the last trimester. In this review, we describe pregnancy induced changes in adrenal function, the diagnosis and management of adrenal insufficiency in pregnancy and areas requiring further research.
- 11 July 2022
- Published by Springer Nature in Reviews in Endocrine and Metabolic Disorders
- Vol. 24 (1) , 57-69
Adrenal insufficiency in pregnancy: Physiology, diagnosis, management and areas for future research
Adrenal insufficiency requires prompt diagnosis in pregnancy, as untreated, it can lead to serious consequences such as adrenal crisis, intrauterine growth restriction and even foetal demise. Similarities between symptoms of adrenal insufficiency and those of normal pregnancy can complicate diagnosis. Previously diagnosed adrenal insufficiency needs monitoring and, often, adjustment of adrenal hormone replacement. Many physiological changes occur to the hypothalamic–pituitary–adrenal (HPA) axis during pregnancy, often making diagnosis and management of adrenal insufficiency challenging. Pregnancy is a state of sustained physiologic hypercortisolaemia; there are multiple contributing factors including high plasma concentrations of placental derived corticotropin-releasing hormone (CRH), adrenocorticotropin (ACTH) and increased adrenal responsiveness to ACTH. Despite increased circulating concentrations of CRH-binding protein (CRH-BP) and the major cortisol binding protein, corticosteroid binding globulin (CBG), free concentrations of both hormones are increased progressively in pregnancy. In addition, pregnancy leads to activation of the renin–angiotensin–aldosterone system. Most adrenocortical hormone diagnostic thresholds are not applicable or validated in pregnancy. The management of adrenal insufficiency also needs to reflect the physiologic changes of pregnancy, often requiring increased doses of glucocorticoid and at times mineralocorticoid replacement, especially in the last trimester. In this review, we describe pregnancy induced changes in adrenal function, the diagnosis and management of adrenal insufficiency in pregnancy and areas requiring further research.
- Open Access
- 7 July 2022
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 13, 910367
Structural Features of Antibody-Peptide Recognition
Antibody recognition of antigens is a critical element of adaptive immunity. One key class of antibody-antigen complexes is comprised of antibodies targeting linear epitopes of proteins, which in some cases are conserved elements of viruses and pathogens of relevance for vaccine design and immunotherapy. Here we report a detailed analysis of the structural and interface features of this class of complexes, based on a set of nearly 200 nonredundant high resolution antibody-peptide complex structures that were assembled from the Protein Data Bank. We found that antibody-bound peptides adopt a broad range of conformations, often displaying limited secondary structure, and that the same peptide sequence bound by different antibodies can in many cases exhibit varying conformations. Propensities of contacts with antibody loops and extent of antibody binding conformational changes were found to be broadly similar to those for antibodies in complex with larger protein antigens. However, antibody-peptide interfaces showed lower buried surface areas and fewer hydrogen bonds than antibody-protein antigen complexes, while calculated binding energy per buried interface area was found to be higher on average for antibody-peptide interfaces, likely due in part to a greater proportion of buried hydrophobic residues and higher shape complementarity. This dataset and these observations can be of use for future studies focused on this class of interactions, including predictive computational modeling efforts and the design of antibodies or epitope-based vaccine immunogens.
- 7 July 2022
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 13, 910367
Open AccessStructural Features of Antibody-Peptide Recognition
Antibody recognition of antigens is a critical element of adaptive immunity. One key class of antibody-antigen complexes is comprised of antibodies targeting linear epitopes of proteins, which in some cases are conserved elements of viruses and pathogens of relevance for vaccine design and immunotherapy. Here we report a detailed analysis of the structural and interface features of this class of complexes, based on a set of nearly 200 nonredundant high resolution antibody-peptide complex structures that were assembled from the Protein Data Bank. We found that antibody-bound peptides adopt a broad range of conformations, often displaying limited secondary structure, and that the same peptide sequence bound by different antibodies can in many cases exhibit varying conformations. Propensities of contacts with antibody loops and extent of antibody binding conformational changes were found to be broadly similar to those for antibodies in complex with larger protein antigens. However, antibody-peptide interfaces showed lower buried surface areas and fewer hydrogen bonds than antibody-protein antigen complexes, while calculated binding energy per buried interface area was found to be higher on average for antibody-peptide interfaces, likely due in part to a greater proportion of buried hydrophobic residues and higher shape complementarity. This dataset and these observations can be of use for future studies focused on this class of interactions, including predictive computational modeling efforts and the design of antibodies or epitope-based vaccine immunogens.
- Open Access
- 2 December 2020
- Published by BMJ in BMJ Open Diabetes Research & Care
- Vol. 8 (2) , e001837
Insulin use and new diabetes after acceptance for bariatric surgery: comparison of outcomes after completion of surgery or withdrawal from the program
Introduction In people accepted onto a bariatric surgery program we compared diabetes-related outcomes in those who completed surgery with those who withdrew before having surgery—examining rates of insulin use in people with type 2 diabetes (T2D), and rates of incident diabetes in people without pre-existing T2D. Research design and methods 771 people were accepted onto the program. 463 people (60%) had T2D at referral, of which 48% completed surgery and 52% withdrew. Of 308 people without T2D at referral, 49% completed surgery, and 51% withdrew. Rates of insulin use and incident diabetes were compared by Kaplan-Meier analyses. Among those with pre-existing T2D, we examined rates of remission and relapse after surgery. Results People without T2D who withdrew from the program had higher mean body mass index and glycated hemoglobin levels than those completing surgery (pConclusions Despite a high relapse rate, people with T2D who completed surgery had lower insulin use at 5 years than those withdrawing from the program. In people without T2D, bariatric surgery prevented incident diabetes. People without T2D who withdrew from the program were at greater risk of diabetes, suggesting those who could benefit the most in terms of T2D prevention are not completing bariatric surgery.
- 2 December 2020
- Published by BMJ in BMJ Open Diabetes Research & Care
- Vol. 8 (2) , e001837
Open AccessInsulin use and new diabetes after acceptance for bariatric surgery: comparison of outcomes after completion of surgery or withdrawal from the program
Introduction In people accepted onto a bariatric surgery program we compared diabetes-related outcomes in those who completed surgery with those who withdrew before having surgery—examining rates of insulin use in people with type 2 diabetes (T2D), and rates of incident diabetes in people without pre-existing T2D. Research design and methods 771 people were accepted onto the program. 463 people (60%) had T2D at referral, of which 48% completed surgery and 52% withdrew. Of 308 people without T2D at referral, 49% completed surgery, and 51% withdrew. Rates of insulin use and incident diabetes were compared by Kaplan-Meier analyses. Among those with pre-existing T2D, we examined rates of remission and relapse after surgery. Results People without T2D who withdrew from the program had higher mean body mass index and glycated hemoglobin levels than those completing surgery (pConclusions Despite a high relapse rate, people with T2D who completed surgery had lower insulin use at 5 years than those withdrawing from the program. In people without T2D, bariatric surgery prevented incident diabetes. People without T2D who withdrew from the program were at greater risk of diabetes, suggesting those who could benefit the most in terms of T2D prevention are not completing bariatric surgery.
- 20 November 2020
- Vol. 133 (1525) , 34-40
Diabetic ketoacidosis admissions at Middlemore Hospital: observational study of cause and patient demographics
AIM: To analyse data on diabetic ketoacidosis (DKA) admissions to better understand characteristics of those presenting with DKA and identify high-risk groups. METHOD: Study population consisted of people with type 1 diabetes discharged from Middlemore Hospital between 01 July 2015 and 30 June 2016 with the diagnosis of DKA. Basic demographic data and socioeconomic status as defined by 2013 New Zealand deprivation index quintiles were obtained, in addition to the cause of DKA. RESULTS: There were 69 DKA admissions from 57 people; 35% were Pasifika and 23% Maori. Fifty-six percent were from quintile 5, the quintile with the lowest socioeconomic status. The most common cause of DKA was non-adherence to insulin (59%), followed by infection (16%) and new diagnosis of type 1 diabetes (14%). There was greater proportion of Pasifika and Maori population in those with non-adherence as the cause. CONCLUSION: Non-adherence is a major cause of DKA admissions at Middlemore Hospital. When compared to the regional census data, there is over-representation of Pasifika and Maori population and those of lower socioeconomic status in those admitted with DKA. Similar pattern was seen in those with non-adherence as the cause of DKA and those with recurrent DKAs.
- 20 November 2020
- Vol. 133 (1525) , 34-40
Diabetic ketoacidosis admissions at Middlemore Hospital: observational study of cause and patient demographics
AIM: To analyse data on diabetic ketoacidosis (DKA) admissions to better understand characteristics of those presenting with DKA and identify high-risk groups. METHOD: Study population consisted of people with type 1 diabetes discharged from Middlemore Hospital between 01 July 2015 and 30 June 2016 with the diagnosis of DKA. Basic demographic data and socioeconomic status as defined by 2013 New Zealand deprivation index quintiles were obtained, in addition to the cause of DKA. RESULTS: There were 69 DKA admissions from 57 people; 35% were Pasifika and 23% Maori. Fifty-six percent were from quintile 5, the quintile with the lowest socioeconomic status. The most common cause of DKA was non-adherence to insulin (59%), followed by infection (16%) and new diagnosis of type 1 diabetes (14%). There was greater proportion of Pasifika and Maori population in those with non-adherence as the cause. CONCLUSION: Non-adherence is a major cause of DKA admissions at Middlemore Hospital. When compared to the regional census data, there is over-representation of Pasifika and Maori population and those of lower socioeconomic status in those admitted with DKA. Similar pattern was seen in those with non-adherence as the cause of DKA and those with recurrent DKAs.